The daughter of former Justice and Development Party (AKP) Vice Chairman and prominent deputy Salih Kapusuz has been revealed to be a lawyer for the intermediary company that bought China’s Coronavirus vaccine for distribution in Turkey.
State-run TRT journalist’s photo refutes Health Minister’s remarks on COVID-19 vaccine deal with China https://t.co/ECNwfouao3 #HDP #Kurds #USA #Congress #Senat @US_EUCOM #EU @EU_Commission @coe #MiddleEast #EastMed #Arab #Gulf
— Friedhelm Hepping (@demian_goldmund) December 28, 2020
Keymen İlaç (Pharmaceuticals) was revealed by a reporter at Turkish state broadcaster to be the intermediary company which purchased the vaccine from China.
Main opposition Republican People’s Party (CHP) deputy Murat Emir had in early December alleged that the Health Ministry would receive the COVID-19 vaccine shipment from China via the company Keymen İlaç. In response, Health Minister Fahrettin Koca had said that Ankara had not used an intermediary firm and the Turkish State Supply Office (DMO) had struck a direct deal with Sinovac itself.
Senanur Kapusuz, a lawyer at the company, announced Tuesday via Twitter account that she received the vaccine during a trial in December. Kapusuz’s last name brought to mind former AKP deputy Salih Kapusuz. Kayseri local press then confirmed that Senanur Kapusuz was the daughter of Salih Kapusuz.
Kapusuz said on her Twitter account on December 4 and in the following days:
“I also volunteered today for the corona vaccine, which is continuing clinical trials of Phase 3, known as the Chinese vaccine, which we brought to Turkey as Keymen Medicine. I thank our chairman of the board, Mr. Cantürk Alagoz, who I am proud to work with, for his extraordinary efforts. One in three vaccines in clinical trials is the placebo vaccine. If there is no empty vaccine, I will see the results clearly in 23 days. I haven’t seen any side effects so far. Voluntary applications made in 25 centers throughout Turkey have been completed. I did not observe any side effects within 14 days of the second dose.”
Keymen İlaç olarak Türkiye’ye getirdiğimiz Çin Aşısı olarak bilinen faz3 klinik çalışmaları devam eden korona aşısı için bugün ben de gönüllü oldum.
Birlikte çalışmaktan gurur duyduğum Yönetim kurulu başkanımız Sn Cantürk Alagöz’e gösterdiği olağanüstü çaba için teşekkür ederim. pic.twitter.com/RubziU1hR7
— Senanur Kapusuz (@snkapusuz) December 4, 2020
Keymen Pharmaceuticals is owned by businessman Canberk Alagöz. The value of the Ankara-based company is 15 million Turkish lira, and its activities include the import and export of vaccine raw materials.
Alagöz, said in a statement on September 16, 2020, “for the transfer of technology to Turkey and the production of the vaccine in our country, under the leadership of the Ministry of Health, China and Turkey have entered into an important cooperation”. Alagöz, who is from Iğdırlı, also made a grant to Iğdır State Hospital for the PCR (Covid-19 test) laboratory.
Following the revelations about the intermediary company, Health Minister Fahrettin Koca published a statement slamming ‘rumors’ about the deal with the Chinese vaccine and about the allegation, but the tweet included a letter in English from Chinese authorities which stated that “Keymen is the exclusive distributor of Sinovac”.
Aşı tedarikinde aracı firma kullanıldığına dair iddialar ile ilgili açıklamamız ektedir. Milletimiz irfan sahibidir. Hakikati görür ve ona sahip çıkar. pic.twitter.com/oCz0erDGqC
— Dr. Fahrettin Koca (@drfahrettinkoca) December 29, 2020
There has also been recent controversy about the legality of the injection of the vaccine. Consul General from Chinese Consulate in Istanbul, during an interview at the pro-government TV, speaking in Turkish, said China is currently not using the vaccine because it has not been appoved yet.
Also another controversy is the price Turkey has paid for the vaccine. Dr Serdar Savaş, former program director of World Health Organisation (WHO) Europe, recently stated that Turkey is paying $70 per vaccine, compared to a deal with Indonesia which is buying the same vaccine for only $13.
Indonesia has signed a contract with China to purchase the Sinovac at $13 per vaccine dose, while Turkey’s contract is for $70 per dose, according to Dr Serdar Savaş, former program director of World Health Organisation (WHO) Europe. https://t.co/CpEEb8meMn
— Ahval (@ahval_en) December 25, 2020